Discontinuation report DEPO-MEDROL WITH LIDOCAINE
Report ID | 64425 |
Drug Identification Number | 00260428 |
Brand name | DEPO-MEDROL WITH LIDOCAINE |
Common or Proper name | Depo-Medrol + Lidocaine |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | LIDOCAINE HYDROCHLORIDE METHYLPREDNISOLONE ACETATE |
Strength(s) | 10MG 40MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRA-ARTICULAR INTRABURSAL |
Packaging size | 1x1ml |
ATC code | H02BX |
ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-10-15 |
Remaining supply date | 2018-10-15 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Format replaced by Depo-Medrol+Lidocaine 40mg/ml 1x2ml. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-10-16 | English | Compare |
v2 | 2018-10-16 | French | Compare |
Showing 1 to 2 of 2